187 related articles for article (PubMed ID: 19876913)
1. Phosphatidylinositol 4,5-bisphosphate-specific AKT1 is oncogenic.
Dannemann N; Hart JR; Ueno L; Vogt PK
Int J Cancer; 2010 Jul; 127(1):239-44. PubMed ID: 19876913
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanism of an oncogenic mutation that alters membrane targeting: Glu17Lys modifies the PIP lipid specificity of the AKT1 PH domain.
Landgraf KE; Pilling C; Falke JJ
Biochemistry; 2008 Nov; 47(47):12260-9. PubMed ID: 18954143
[TBL] [Abstract][Full Text] [Related]
3. Requirement of phosphatidylinositol(3,4,5)trisphosphate in phosphatidylinositol 3-kinase-induced oncogenic transformation.
Denley A; Gymnopoulos M; Kang S; Mitchell C; Vogt PK
Mol Cancer Res; 2009 Jul; 7(7):1132-8. PubMed ID: 19584261
[TBL] [Abstract][Full Text] [Related]
4. The GRP1 PH domain, like the AKT1 PH domain, possesses a sentry glutamate residue essential for specific targeting to plasma membrane PI(3,4,5)P(3).
Pilling C; Landgraf KE; Falke JJ
Biochemistry; 2011 Nov; 50(45):9845-56. PubMed ID: 21932773
[TBL] [Abstract][Full Text] [Related]
5. Regulation of PI3K effector signalling in cancer by the phosphoinositide phosphatases.
Rodgers SJ; Ferguson DT; Mitchell CA; Ooms LM
Biosci Rep; 2017 Feb; 37(1):. PubMed ID: 28082369
[TBL] [Abstract][Full Text] [Related]
6. Phosphatidylinositol 3-kinase-dependent activation of mammalian protein kinase B/Akt in Saccharomyces cerevisiae, an in vivo model for the functional study of Akt mutations.
Rodríguez-Escudero I; Andrés-Pons A; Pulido R; Molina M; Cid VJ
J Biol Chem; 2009 May; 284(20):13373-13383. PubMed ID: 19307184
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
Korkolopoulou P; Levidou G; Trigka EA; Prekete N; Karlou M; Thymara I; Sakellariou S; Fragkou P; Isaiadis D; Pavlopoulos P; Patsouris E; Saetta AA
BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319
[TBL] [Abstract][Full Text] [Related]
8. Functional analysis of non-hotspot AKT1 mutants found in human breast cancers identifies novel driver mutations: implications for personalized medicine.
Yi KH; Axtmayer J; Gustin JP; Rajpurohit A; Lauring J
Oncotarget; 2013 Jan; 4(1):29-34. PubMed ID: 23237847
[TBL] [Abstract][Full Text] [Related]
9. Disruption of PH-kinase domain interactions leads to oncogenic activation of AKT in human cancers.
Parikh C; Janakiraman V; Wu WI; Foo CK; Kljavin NM; Chaudhuri S; Stawiski E; Lee B; Lin J; Li H; Lorenzo MN; Yuan W; Guillory J; Jackson M; Rondon J; Franke Y; Bowman KK; Sagolla M; Stinson J; Wu TD; Wu J; Stokoe D; Stern HM; Brandhuber BJ; Lin K; Skelton NJ; Seshagiri S
Proc Natl Acad Sci U S A; 2012 Nov; 109(47):19368-73. PubMed ID: 23134728
[TBL] [Abstract][Full Text] [Related]
10. Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer.
Juanpere N; Agell L; Lorenzo M; de Muga S; López-Vilaró L; Murillo R; Mojal S; Serrano S; Lorente JA; Lloreta J; Hernández S
Hum Pathol; 2012 Oct; 43(10):1573-82. PubMed ID: 22417847
[TBL] [Abstract][Full Text] [Related]
11. Interaction of human biliverdin reductase with Akt/protein kinase B and phosphatidylinositol-dependent kinase 1 regulates glycogen synthase kinase 3 activity: a novel mechanism of Akt activation.
Miralem T; Lerner-Marmarosh N; Gibbs PE; Jenkins JL; Heimiller C; Maines MD
FASEB J; 2016 Aug; 30(8):2926-44. PubMed ID: 27166089
[TBL] [Abstract][Full Text] [Related]
12. A transforming mutation in the pleckstrin homology domain of AKT1 in cancer.
Carpten JD; Faber AL; Horn C; Donoho GP; Briggs SL; Robbins CM; Hostetter G; Boguslawski S; Moses TY; Savage S; Uhlik M; Lin A; Du J; Qian YW; Zeckner DJ; Tucker-Kellogg G; Touchman J; Patel K; Mousses S; Bittner M; Schevitz R; Lai MH; Blanchard KL; Thomas JE
Nature; 2007 Jul; 448(7152):439-44. PubMed ID: 17611497
[TBL] [Abstract][Full Text] [Related]
13. Akt-mediated regulation of NFkappaB and the essentialness of NFkappaB for the oncogenicity of PI3K and Akt.
Bai D; Ueno L; Vogt PK
Int J Cancer; 2009 Dec; 125(12):2863-70. PubMed ID: 19609947
[TBL] [Abstract][Full Text] [Related]
14. Transformation of chicken cells by the gene encoding the catalytic subunit of PI 3-kinase.
Chang HW; Aoki M; Fruman D; Auger KR; Bellacosa A; Tsichlis PN; Cantley LC; Roberts TM; Vogt PK
Science; 1997 Jun; 276(5320):1848-50. PubMed ID: 9188528
[TBL] [Abstract][Full Text] [Related]
15. PI3K/AKT pathway activation in acute myeloid leukaemias is not associated with AKT1 pleckstrin homology domain mutation.
Tibes R; Kornblau SM; Qiu Y; Mousses SM; Robbins C; Moses T; Carpten JD
Br J Haematol; 2008 Feb; 140(3):344-7. PubMed ID: 18053070
[TBL] [Abstract][Full Text] [Related]
16. Phosphatidylinositol Phosphate 5-Kinase Iγ and Phosphoinositide 3-Kinase/Akt Signaling Couple to Promote Oncogenic Growth.
Thapa N; Choi S; Tan X; Wise T; Anderson RA
J Biol Chem; 2015 Jul; 290(30):18843-54. PubMed ID: 26070568
[TBL] [Abstract][Full Text] [Related]
17. The oncogenic mutation in the pleckstrin homology domain of AKT1 in endometrial carcinomas.
Shoji K; Oda K; Nakagawa S; Hosokawa S; Nagae G; Uehara Y; Sone K; Miyamoto Y; Hiraike H; Hiraike-Wada O; Nei T; Kawana K; Kuramoto H; Aburatani H; Yano T; Taketani Y
Br J Cancer; 2009 Jul; 101(1):145-8. PubMed ID: 19491896
[TBL] [Abstract][Full Text] [Related]
18. Postreceptoral adipocyte insulin resistance induced by nelfinavir is caused by insensitivity of PKB/Akt to phosphatidylinositol-3,4,5-trisphosphate.
Kachko I; Maissel A; Mazor L; Ben-Romano R; Watson RT; Hou JC; Pessin JE; Bashan N; Rudich A
Endocrinology; 2009 Jun; 150(6):2618-26. PubMed ID: 19179444
[TBL] [Abstract][Full Text] [Related]
19. Reconstitution of the mammalian PI3K/PTEN/Akt pathway in yeast.
Rodríguez-Escudero I; Roelants FM; Thorner J; Nombela C; Molina M; Cid VJ
Biochem J; 2005 Sep; 390(Pt 2):613-23. PubMed ID: 15913452
[TBL] [Abstract][Full Text] [Related]
20. The type Ialpha inositol polyphosphate 4-phosphatase generates and terminates phosphoinositide 3-kinase signals on endosomes and the plasma membrane.
Ivetac I; Munday AD; Kisseleva MV; Zhang XM; Luff S; Tiganis T; Whisstock JC; Rowe T; Majerus PW; Mitchell CA
Mol Biol Cell; 2005 May; 16(5):2218-33. PubMed ID: 15716355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
